2012
DOI: 10.1016/j.surg.2011.06.026
|View full text |Cite
|
Sign up to set email alerts
|

Immunosuppressants accelerate microvascular thrombus formation in vivo: Role of endothelial cell activation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(15 citation statements)
references
References 49 publications
0
15
0
Order By: Relevance
“…In our study, older and heavier heart transplant recipients appeared to be at greater risk for developing LEDVT, while the use of older donors was associated with the development of UEDVT. An additional risk factor for VTE is the need for maintenance immunosuppressive drugs that may have prothrombotic side effects . Patients who were treated with proliferation signal inhibitors at any time post‐transplant, such as everolimus and sirolimus, were significantly more likely to develop PE compared to all patients (54% vs. 29%; p = 0.01).…”
Section: Discussionmentioning
confidence: 99%
“…In our study, older and heavier heart transplant recipients appeared to be at greater risk for developing LEDVT, while the use of older donors was associated with the development of UEDVT. An additional risk factor for VTE is the need for maintenance immunosuppressive drugs that may have prothrombotic side effects . Patients who were treated with proliferation signal inhibitors at any time post‐transplant, such as everolimus and sirolimus, were significantly more likely to develop PE compared to all patients (54% vs. 29%; p = 0.01).…”
Section: Discussionmentioning
confidence: 99%
“…The use of some immunosuppressant medications has been shown to enhance systemic thrombogenicity as well as elevate levels of sP-sel. 26,27 As 15% of our study population was on some form of immunosuppression, we found it prudent to include these patients. However, in univariate analysis, there was no difference in the number of patients on immunosuppression that had a duplex-confirmed LE-DVT compared with those who did not have an LE-DVT.…”
Section: Discussionmentioning
confidence: 99%
“…Prior to photochemical thrombus induction, capillary perfusion and microhemodynamics in randomly chosen venules (diameter range: 30-70 μm) were assessed by means of a ×20 objective (LUCPlanFL ×20/0.45 W, Olympus). Subsequently, photochemical thrombus formation was induced by continuous local exposure of filtered light (450-490/>520 nm excitation/emission wavelength) using a ×63 water immersion objective (Achroplanx63/0.95 W, Zeiss), as described previously by our group (26, 27). The light/dye thrombus model used is based on endothelial injury upon phototoxicity induced by exposure of FITC-dextran to excitation light.…”
Section: Methodsmentioning
confidence: 99%